Gilead Sciences Inc (NASDAQ:GILD)

91.55
Data as of Jul 31
 -2.24 / -2.39%
Today’s Change
55.96
Today|||52-Week Range
94.34
+21.90%
Year-to-Date
Biotechs With High Reward Potential
Jul 31 / Investing Channel
Why Gilead Sciences, inc. Stock Was Flat Today
Jul 24 / MotleyFool.com
Can the Earnings Rebound be Sustained? - Earnings Outlook
Jul 31 / Zacks.com
3 Crucial Quotes From Gilead Sciences Stock
Jul 24 / MotleyFool.com
Can the Earnings Rebound be Sustained? - Earnings Trends
Jul 31 / Zacks.com
Alexion Pharmaceuticals Q2 Earnings In Line; Revises View - Analyst Blog
Jul 24 / Zacks.com
Drug pricing: Bitter pill
Jul 31 / FT.com
What Gilead Stock's Latest Blockbuster Approval Means for Investors
Jul 24 / MotleyFool.com
Stock Market News for July 31, 2014 - Market News
Jul 31 / Zacks.com
Healthcare Spending to Trend Up in 2015: 3 Healthcare Fund Picks - Best of Funds
Jul 24 / Zacks.com
Biotech Earnings Put These ETFs in Focus - ETF News And Commentary
Jul 31 / Zacks.com
3 Game-Changing Stories That Shook Investors: Inovio Pharmaceuticals, Gilead Sciences...
Jul 24 / MotleyFool.com
Biotech Valuations Are Low Not Stretched. Here's Why.
Jul 31 / TheStreet.com
Stock Market News for July 24, 2014 - Market News
Jul 24 / Zacks.com
Biotech Stock Roundup: Gilead's Sovaldi & Biogen's Tecfidera Impressive Run Continues...
Jul 30 / Zacks.com
Gilead Crushes Q2 Earnings Estimates as Sovaldi Sales Soar - Analyst Blog
Jul 24 / Zacks.com
Why Humana (HUM) Stock Is Declining Today
Jul 30 / TheStreet.com
Gilead Stock's Great Expectations and Giant Opportunity
Jul 23 / MotleyFool.com
Bizarro World Continues
Jul 30 / TheStreet.com
Gilead Sciences Crushes Second-Quarter Earnings
Jul 23 / MotleyFool.com
Jim Cramer's Mad Dash: Good News for Regeneron
Jul 30 / TheStreet.com
Is Gilead About to Crush Pharmacyclics Stock?
Jul 23 / MotleyFool.com
Stock Market News for July 30, 2014 - Market News
Jul 30 / Zacks.com
Why Do We Watch the Dow Jones So Closely When its Makeup Makes No Sense?
Jul 23 / MotleyFool.com
3 Stocks Boosting The Drugs Industry Higher
Jul 29 / TheStreet.com
Biotech Stock Roundup: AbbVie's Tax Inversion, Amgen Drug Scores in Phase 3 - Analyst...
Jul 23 / Zacks.com
Gilead Sciences, Inc. (GILD): The Bullish Case For The Stock
Jul 29 / Investing Channel
3 Stocks to Get on Your Watchlist
Jul 23 / MotleyFool.com
Gilead's Oncology Drug Recommended for Approval in the EU - Analyst Blog
Jul 28 / Zacks.com
3 Things You Need to Watch on Gilead Sciences Inc. Earnings Call
Jul 22 / MotleyFool.com
Pharmacyclics/Johnson & Johnson Drug Backed for EU Approval - Analyst Blog
Jul 28 / Zacks.com
3 Quotes From Johnson & Johnson's Conference Call You Need to Read
Jul 22 / MotleyFool.com
Why Ibm Bullish On Gilead Sciences, Inc. (GILD)
Jul 28 / Investing Channel
Will Gilead (GILD) Earnings Disappoint in Q2 as Costs Rise? - Analyst Blog
Jul 22 / Zacks.com
Amgen Shares Have the Right Prescription for Long-Term Growth
Jul 28 / TheStreet.com
Do This Drug's Sales Make J&J a Hepatitis C Powerhouse?
Jul 22 / MotleyFool.com
Why Gilead Sciences (GILD) Stock Is Up Today
Jul 28 / TheStreet.com
Gilead Earnings: Can Sovaldi Reach $3 Billion?
Jul 21 / MotleyFool.com
#PreMarket Primer: Monday, July 28: Tension Between U.S. And Israel On The Rise
Jul 28 / Benzinga
Yellen Hates Biotech Stocks! Should You?
Jul 21 / MotleyFool.com
Time may be up for tech 'game changers'
Jul 28 / FT.com
Gilead Sciences Stock's Huge Hidden Opportunity
Jul 18 / MotleyFool.com
I'm Less Skeptical After These Results
Jul 25 / TheStreet.com
Americans stock up on Tylenol, baby products
Jul 15 / CNNMoney.com
Why Gilead Stock's Newest Drug Approval Isn't a Gamechanger
Jul 25 / MotleyFool.com
Beware of social media, biotech stocks
Jul 15 / CNNMoney.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.